7月2日，晶泰控股盘中上涨5.1%，报7.78港元，成交额2.91亿港元。
消息面上，公司近期利好密集释放：AI自主实验工作站近日正式落地中石化，标志着其"AI+机器人"平台向材料科学领域拓展取得实质性进展；此前公司宣布与国际知名药企达成超4亿美元AI药物发现战略合作，聚焦GPCR靶点口服小分子疗法；同时1亿美元股份回购计划自6月10日起持续实施，彰显管理层对公司价值的信心。当日生命科学板块整体走强，金斯瑞生物科技涨4.17%，药明生物涨3.06%，药明合联涨2.89%，板块共振助推股价表现。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.